GlassScriptPhysician profile
Matthew Ryan Feltner
NPI 1932462645
$37,590.08
in general payments reported to CMS, 2019-2025
26 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,836 · 2020: $8,573 · 2021: $9,060 · 2022: $4,687 · 2023: $4,982 · 2024: $1,176 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,873 · Consulting Fee: $2,250 · Food and Beverage: $1,311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,873.42 |
| Consulting Fee | $2,250.00 |
| Food and Beverage | $1,310.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flower Orthopedics Coporation | $19,842.70 | 2019-2021 | |
| Ortho Solutions INC | $4,778.20 | 2022-2023 | |
| Arthrex, INC. | $3,446.33 | 2019-2021 | |
| Vilex LLC | $2,873.42 | 2023 | |
| Alpha Orthopedic Systems | $2,421.94 | 2019-2021 | |
| Bone Support INC. | $2,250.00 | 2023-2024 | Ceramentbone Void Filler, Cerament G |
| Mimedx Group, INC. | $617.36 | 2024-2025 | |
| Stryker Corporation | $315.51 | 2021-2022 | |
| Melinta Therapeutics, LLC | $179.10 | 2019-2022 | |
| Pacira Therapeutics, INC. | $125.94 | 2019-2021 | |
| Wright Medical Technology, INC. | $122.34 | 2019 | |
| Orthofix Medical, INC. | $121.81 | 2023 | Trinity Elite, Truelok System, Truelok |
| Kerecis Limited | $105.00 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Amgen INC. | $96.65 | 2023-2025 | Evenity, Prolia |
| Polynovo North America LLC | $44.70 | 2024-2025 | Novosorb Btm |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $41.06 | 2024-2025 | |
| Smith+Nephew, INC. | $40.66 | 2022-2023 | Collagenase Santyl |
| Urgo Medical North America, LLC | $31.51 | 2024 | Urgok2 |
| Treace Medical Concepts, INC. | $30.00 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $22.18 | 2022 | |
| Novo Nordisk INC | $17.53 | 2019 | |
| Reprise Biomedical, INC. | $15.51 | 2024 | Miro3d |
| Radius Health, INC. | $14.28 | 2021 | |
| Tei Medical INC. | $12.75 | 2019 | |
| Osiris Therapeutics INC. | $12.13 | 2019 | |
| Merck Sharp & Dohme LLC | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Feltner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.